COHERUS BIOSCIENCES INC's ticker is CHRS and the CUSIP is 19249H103. A total of 191 filers reported holding COHERUS BIOSCIENCES INC in Q2 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $6,010,000 | -5.3% | 434,555 | 0.0% | 0.35% | -9.4% |
| Q1 2021 | $6,349,000 | -15.9% | 434,555 | 0.0% | 0.38% | -15.1% |
| Q4 2020 | $7,553,000 | -5.2% | 434,555 | 0.0% | 0.45% | -23.9% |
| Q3 2020 | $7,970,000 | -76.9% | 434,555 | -77.5% | 0.59% | -72.9% |
| Q2 2020 | $34,527,000 | +10.1% | 1,933,221 | 0.0% | 2.18% | -25.0% |
| Q1 2020 | $31,357,000 | -9.9% | 1,933,221 | 0.0% | 2.90% | +15.6% |
| Q4 2019 | $34,808,000 | -11.1% | 1,933,221 | 0.0% | 2.51% | -29.1% |
| Q3 2019 | $39,167,000 | -15.3% | 1,933,221 | -7.6% | 3.54% | -16.7% |
| Q2 2019 | $46,260,000 | +18.2% | 2,093,221 | -27.0% | 4.25% | +12.7% |
| Q1 2019 | $39,123,000 | +50.7% | 2,868,221 | 0.0% | 3.77% | +16.6% |
| Q4 2018 | $25,957,000 | -45.2% | 2,868,221 | 0.0% | 3.23% | -23.3% |
| Q3 2018 | $47,326,000 | -41.6% | 2,868,221 | -50.4% | 4.22% | -18.3% |
| Q2 2018 | $81,010,000 | +153.4% | 5,786,442 | +100.0% | 5.17% | -6.0% |
| Q1 2018 | $31,970,000 | – | 2,893,221 | – | 5.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 650,000 | $10,374,000 | 2.09% |
| CM Management, LLC | 125,000 | $1,995,000 | 1.51% |
| Perceptive Advisors | 10,815,596 | $172,616,000 | 1.33% |
| Bridge City Capital, LLC | 163,198 | $2,605,000 | 1.07% |
| Phocas Financial Corp. | 514,438 | $8,210,000 | 1.04% |
| Redwood Investments, LLC | 709,184 | $11,319,000 | 0.89% |
| Aristotle Capital Boston, LLC | 2,087,187 | $33,312,000 | 0.78% |
| Knott David M Jr | 102,555 | $1,637,000 | 0.56% |
| Zebra Capital Management LLC | 16,746 | $267,000 | 0.43% |
| Temasek Holdings (Private) Ltd | 7,381,116 | $117,803,000 | 0.42% |